← Evidence library

BIB_424

Dermatologic screening + method → Breslow thickness at diagnosis: the evidence that reframes this patient's LIFELONG second-primary surveillance (TASK05) from "anxious checking" to "the single intervention that shifts a future melanoma ~1 mm thinner / often in situ" — and, crucially for a refugee with imperfect access, shows even IRREGULAR screening delivers the bulk of the benefit. Fills a real gap: existing surveillance BIBs cover 3D-TBP/digital-monitoring efficacy in high-risk monitoring (BIB104/284/383) but none anchored the screening-access → stage-at-detection relationship or the irreg…

Evidence grade

B

Tier

2 (sin

Cited by tasks

5, 5a, 8b, 14

Identifiers

PMC12897046

↗ Follow the original source for full context

Full extracted findings & patient-implication analysis: bibliography/BIB_424/findings.md (research corpus). This page is a short context summary — not individualised medical advice.